Johan M. Spoor
Known title: CEOCIK: 0001535289
Johan M. Spoor's purchase track record
How the stock did after each of Johan M. Spoor's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since June 13, 2024
Stock higher 6 months later
25%
3 months: 50%
Median 6-month return
-25.3%
3 months: +5.3%
Beat the S&P 500
25%
median -23.8% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/28/2025 | CATX | $60K | +70.9% | +54.5% | +19.0% |
| 12/4/2024 | CATX | $30K | -31.8% | -15.6% | -1.9% |
| 11/25/2024 | CATX | $100K | -26.0% | -35.0% | -1.1% |
| 6/13/2024 | CATX | $117K | +36.5% | -70.1% | +11.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CATX | ▲ Buy | Open Market | 22,026 | $49K | 3/28/2025 | View on chart |
| CATX | ▲ Buy | Open Market | 4,650 | $10K | 3/28/2025 | View on chart |
| CATX | ▲ Buy | Open Market | 8,000 | $30K | 12/4/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 14,500 | $55K | 11/25/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 5,400 | $21K | 11/25/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 6,600 | $25K | 11/25/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 100,000 | $117K | 6/13/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
CATX included in pre-market movers list
Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.
CATX included in pre-market movers list. Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.